Varian Medical Systems, Inc. (NYSE:VAR) EVP Kolleen T. Kennedy sold 1,088 shares of the company’s stock in a transaction that occurred on Tuesday, September 12th. The shares were sold at an average price of $107.33, for a total value of $116,775.04. Following the sale, the executive vice president now owns 27,688 shares in the company, valued at approximately $2,971,753.04. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.

Shares of Varian Medical Systems, Inc. (VAR) traded down 1.43% during mid-day trading on Friday, hitting $106.33. The stock had a trading volume of 989,902 shares. The firm has a 50 day moving average of $101.57 and a 200 day moving average of $97.37. The stock has a market cap of $9.76 billion, a price-to-earnings ratio of 35.00 and a beta of 0.58. Varian Medical Systems, Inc. has a one year low of $75.20 and a one year high of $107.87.

Varian Medical Systems (NYSE:VAR) last announced its quarterly earnings results on Wednesday, July 26th. The medical equipment provider reported $1.04 EPS for the quarter, topping analysts’ consensus estimates of $0.95 by $0.09. The firm had revenue of $662.40 million during the quarter, compared to analysts’ expectations of $663.86 million. Varian Medical Systems had a net margin of 9.50% and a return on equity of 24.70%. The company’s revenue for the quarter was up 3.0% compared to the same quarter last year. During the same quarter last year, the company earned $1.00 earnings per share. On average, analysts forecast that Varian Medical Systems, Inc. will post $3.93 earnings per share for the current year.

COPYRIGHT VIOLATION WARNING: “Varian Medical Systems, Inc. (VAR) EVP Sells $116,775.04 in Stock” was reported by Daily Political and is the property of of Daily Political. If you are reading this news story on another domain, it was illegally copied and republished in violation of United States and international trademark & copyright law. The correct version of this news story can be read at https://www.dailypolitical.com/2017/09/16/varian-medical-systems-inc-var-evp-sells-116775-04-in-stock.html.

Several brokerages have issued reports on VAR. BidaskClub upgraded Varian Medical Systems from a “sell” rating to a “hold” rating in a research note on Saturday, August 12th. BTIG Research cut Varian Medical Systems from a “buy” rating to a “neutral” rating in a research note on Thursday, September 7th. They noted that the move was a valuation call. Robert W. Baird restated a “neutral” rating and set a $99.00 price objective (up previously from $89.00) on shares of Varian Medical Systems in a research note on Friday, July 14th. Finally, Zacks Investment Research cut Varian Medical Systems from a “buy” rating to a “hold” rating in a research note on Thursday, July 13th. Two analysts have rated the stock with a sell rating, eight have given a hold rating and two have assigned a buy rating to the stock. The stock presently has a consensus rating of “Hold” and an average target price of $97.39.

Institutional investors and hedge funds have recently made changes to their positions in the business. Manchester Capital Management LLC lifted its stake in Varian Medical Systems by 16.5% during the second quarter. Manchester Capital Management LLC now owns 1,057 shares of the medical equipment provider’s stock worth $109,000 after purchasing an additional 150 shares during the period. First Mercantile Trust Co. lifted its stake in Varian Medical Systems by 2.3% during the first quarter. First Mercantile Trust Co. now owns 1,093 shares of the medical equipment provider’s stock worth $100,000 after purchasing an additional 25 shares during the period. Parallel Advisors LLC lifted its stake in Varian Medical Systems by 16.7% during the first quarter. Parallel Advisors LLC now owns 1,232 shares of the medical equipment provider’s stock worth $113,000 after purchasing an additional 176 shares during the period. Heritage Trust Co bought a new position in Varian Medical Systems during the first quarter worth about $118,000. Finally, Penserra Capital Management LLC lifted its stake in Varian Medical Systems by 9.5% during the first quarter. Penserra Capital Management LLC now owns 1,610 shares of the medical equipment provider’s stock worth $146,000 after purchasing an additional 140 shares during the period. Hedge funds and other institutional investors own 99.64% of the company’s stock.

Varian Medical Systems Company Profile

Varian Medical Systems, Inc is a manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy.

Insider Buying and Selling by Quarter for Varian Medical Systems (NYSE:VAR)

Receive News & Ratings for Varian Medical Systems Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Varian Medical Systems Inc. and related companies with MarketBeat.com's FREE daily email newsletter.